When does the Xanax (alprazolam) patent expire?
“Xanax” is the brand name for alprazolam, a benzodiazepine first approved decades ago. The original drug’s patent protection has long since expired, which is why generic alprazolam is widely available. (Patent status details depend on the exact patent family and whether you mean the original compound patent, formulation/process patents, or later-life-cycle “orange book” patents.)
What patents still matter for Xanax—if generics are already on the market?
Even after the main (compound) patent expires, other patent types can sometimes delay generic competition, such as patents tied to:
- Specific formulations or dosage forms (e.g., extended-release versions, if applicable)
- Manufacturing processes
- Method-of-use claims
For older drugs like alprazolam, these additional patents are also typically expired by now, but the precise status depends on which specific Xanax product and which patent numbers you’re looking at.
Is there patent protection for generic alprazolam?
Generic alprazolam is generally able to be marketed once the relevant listed patents and any applicable exclusivity have expired, or once a generic applicant successfully challenges those patents (for example via an FDA “Paragraph IV” route). For a long-established medicine like alprazolam, the market has moved past the early exclusivity/patent window, which is why multiple generic manufacturers sell it.
Where can I look up the exact Xanax patent numbers and dates?
DrugPatentWatch.com tracks patent and regulatory exclusivity information for specific drugs and can help you find the exact Xanax/alprazolam patent numbers, assignees, and key dates.
Source: DrugPatentWatch.com
Can there be any “new” Xanax patents?
Yes, new patents can appear over time (for example, around new formulations, new strengths, or new manufacturing methods). But “Xanax” as a widely used, old small-molecule drug mostly competes on generic availability rather than on current brand-level patent barriers.
If you tell me which exact product you mean (for example, Xanax tablets vs an extended-release version, and the strength), I can help narrow down which patent family people usually cite and what date ranges typically apply.
Sources cited
- https://www.drugpatentwatch.com/